• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受长期血液透析治疗患者的尿毒症性肿瘤性钙化

Uremic tumoral calcinosis in patients receiving longterm hemodialysis therapy.

作者信息

Cofan F, García S, Combalia A, Campistol J M, Oppenheimer F, Ramón R

机构信息

Orthopedic Department, Hospital Clinic, University of Barcelona, Spain.

出版信息

J Rheumatol. 1999 Feb;26(2):379-85.

PMID:9972973
Abstract

OBJECTIVE

To analyze a series of uremic tumoral calcinosis (UTC) in patients receiving longterm dialysis therapy.

METHODS

Twelve patients receiving longterm hemodialysis affected by tumoral calcinosis were analyzed. Clinical, radiological, and pathological features were evaluated and pathogenic factors were reviewed.

RESULTS

The most common sites for UTC were the elbow, hip, hand, and wrist. The lesions were multiple (67%, n = 8), of large size, and symptomatic with joint mobility impairment (75%, n = 9) as well as nerve compression (33%, n = 4). High serum calcium and phosphate concentrations were detected in 50% (n = 6) and 100% of the patients, respectively. An increased calcium-phosphorus product (Ca x P) was observed in all patients, either due to overt secondary hyperparathyroidism (42%, n = 5), or secondary to iatrogenic hypercalcemia and/or severe hyperphosphoremia of multifactorial etiology (i.e., prolonged and excessive administration of calcitriol and calcium carbonate, insufficient dialysis and inadequate phosphorus chelating therapy, etc.) (58%, n = 7). Several treatment strategies were followed (surgical excision, parathyroidectomy, renal transplant) in combination with aggressive medical therapy to decrease Ca x P product, achieving complete remission in 83% of the patients.

CONCLUSION

UTC lesions show clinical and pathogenic features that differ from those of idiopathic tumoral calcinosis. The most important pathogenic factor involved in UTC is an increase in Ca x P, not necessarily related to hyperparathyroidism. Combined treatment strategies allow complete remission in a high proportion of patients. A low Ca x P is necessary to prevent development of UTC.

摘要

目的

分析接受长期透析治疗的一系列尿毒症性肿瘤性钙化(UTC)患者。

方法

对12例接受长期血液透析且患有肿瘤性钙化的患者进行分析。评估临床、放射学和病理学特征,并回顾致病因素。

结果

UTC最常见的部位是肘部、髋部、手部和腕部。病变为多发(67%,n = 8),体积较大,有症状,表现为关节活动受限(75%,n = 9)以及神经受压(33%,n = 4)。分别在50%(n = 6)和100%的患者中检测到高血清钙和磷浓度。所有患者均观察到钙磷乘积(Ca×P)升高,这要么是由于明显的继发性甲状旁腺功能亢进(42%,n = 5),要么是继发于医源性高钙血症和/或多因素病因导致的严重高磷血症(即骨化三醇和碳酸钙的长期过量给药、透析不足和磷螯合治疗不充分等)(58%,n = 7)。采取了多种治疗策略(手术切除、甲状旁腺切除术、肾移植)并联合积极的药物治疗以降低Ca×P乘积,83%的患者实现了完全缓解。

结论

UTC病变显示出与特发性肿瘤性钙化不同的临床和致病特征。UTC中最重要的致病因素是Ca×P升高,不一定与甲状旁腺功能亢进有关。联合治疗策略可使高比例患者实现完全缓解。低Ca×P对于预防UTC的发生是必要的。

相似文献

1
Uremic tumoral calcinosis in patients receiving longterm hemodialysis therapy.接受长期血液透析治疗患者的尿毒症性肿瘤性钙化
J Rheumatol. 1999 Feb;26(2):379-85.
2
Uremic tumoral calcinosis in hemodialysis patients: clinicopathological findings and identification of calcific deposits.血液透析患者的尿毒症性肿瘤性钙化:临床病理表现及钙化沉积物的鉴定
J Rheumatol. 2006 Jan;33(1):119-26.
3
[Tumorous calcinosis in hemodialysis: anatomo-clinical study apropos of 3 cases].[血液透析中的肿瘤性钙化:关于3例病例的解剖临床研究]
Nephrologie. 2001;22(7):349-52.
4
Uremic tumoral calcinosis in patients on peritoneal dialysis: clinical, radiologic, and laboratory features.尿毒症性肿瘤样钙质沉着症在腹膜透析患者中的临床、放射学和实验室特征。
Perit Dial Int. 2011 Jul-Aug;31(4):430-9. doi: 10.3747/pdi.2009.00250. Epub 2011 Feb 28.
5
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
6
Treatment of Uremic Tumoral Calcinosis in Maintenance Hemodialysis Patients.维持性血液透析患者尿毒症性肿瘤性钙化的治疗。
Blood Purif. 2020;49(6):658-664. doi: 10.1159/000506115. Epub 2020 Apr 14.
7
[Clinical characteristics of 10 patients with uremic tumoral calcinosis].10例尿毒症性肿瘤性钙化患者的临床特征
Zhonghua Nei Ke Za Zhi. 2020 Nov 1;59(11):860-865. doi: 10.3760/cma.j.cn112138-20200305-00193.
8
Diffuse uremic tumoral calcinosis in a patient on long-term hemodialysis.长期血液透析患者的弥漫性尿毒症性肿瘤性钙化。
J Clin Rheumatol. 2011 Aug;17(5):272-4. doi: 10.1097/RHU.0b013e3182288acd.
9
Tumoral calcinosis, calciphylaxis, hyperparathyroidism and tuberculosis in a dialysis patient.一名透析患者出现肿瘤性钙化、钙过敏、甲状旁腺功能亢进和结核病。
Saudi J Kidney Dis Transpl. 2011 Mar;22(2):306-10.
10
Uremic tumoral calcinosis causing atlantoaxial subluxation and spinal cord compression in a patient on continuous ambulatory peritoneal dialysis.血液透析患者发生持续性不卧床腹膜透析致尿毒症性肿瘤性钙化引起寰枢椎半脱位和脊髓压迫
Int Urol Nephrol. 2013 Oct;45(5):1511-6. doi: 10.1007/s11255-012-0215-z. Epub 2012 Jun 21.

引用本文的文献

1
An Unusual Case of Uremic Tumoral Calcinosis with Atypical Manifestation in a Patient on Peritoneal Dialysis: Case Report and Review of the Literature.腹膜透析患者中表现不典型的尿毒症性肿瘤性钙化罕见病例:病例报告及文献复习
Med Sci (Basel). 2025 Jan 29;13(1):11. doi: 10.3390/medsci13010011.
2
New method of local adjuvant therapy with bicarbonate Ringer's solution for tumoral calcinosis: A case report.用碳酸氢盐林格氏液进行肿瘤性钙化局部辅助治疗的新方法:一例报告。
World J Orthop. 2024 Mar 18;15(3):302-309. doi: 10.5312/wjo.v15.i3.302.
3
Tumoral calcinosis of unusual location in a chronic hemodialysis patient.
一名慢性血液透析患者出现罕见部位的肿瘤性钙化症。
BJR Case Rep. 2023 Feb 15;9(2):20220083. doi: 10.1259/bjrcr.20220083. eCollection 2023 Mar.
4
New bone-like tissue formation in calcific tendinopathy: A case report.钙化性肌腱病中的新骨样组织形成:一例报告。
Bone Rep. 2021 Apr 6;14:101062. doi: 10.1016/j.bonr.2021.101062. eCollection 2021 Jun.
5
Tumoral calcinosis in the cervical spine: a case report and review of the literature.颈椎肿瘤性钙化症:一例报告并文献复习
J Med Case Rep. 2017 Oct 27;11(1):304. doi: 10.1186/s13256-017-1474-1.
6
Tumoral calcinosis in a patient with hypoparathyroidism, sensorineural deafness, and renal dysplasia syndrome undergoing hemodialysis.一名患有甲状旁腺功能减退、感音神经性耳聋和肾发育不良综合征且正在接受血液透析的患者出现肿瘤性钙化。
Clin Case Rep. 2015 Feb;3(2):73-5. doi: 10.1002/ccr3.125. Epub 2015 Jan 22.
7
Uremic tumoral calcinosis causing atlantoaxial subluxation and spinal cord compression in a patient on continuous ambulatory peritoneal dialysis.血液透析患者发生持续性不卧床腹膜透析致尿毒症性肿瘤性钙化引起寰枢椎半脱位和脊髓压迫
Int Urol Nephrol. 2013 Oct;45(5):1511-6. doi: 10.1007/s11255-012-0215-z. Epub 2012 Jun 21.
8
Mineral metabolism and aging: the fibroblast growth factor 23 enigma.矿物质代谢与衰老:成纤维细胞生长因子23之谜
Curr Opin Nephrol Hypertens. 2007 Jul;16(4):311-8. doi: 10.1097/MNH.0b013e3281c55eca.
9
Vitamin D and aging: old concepts and new insights.维生素D与衰老:旧观念与新见解
J Nutr Biochem. 2007 Dec;18(12):771-7. doi: 10.1016/j.jnutbio.2007.02.002. Epub 2007 May 24.